Navigation Links
Glutamate neurotransmission system may be involved with depression risk
Date:11/13/2012

Researchers using a new approach to identifying genes associated with depression have found that variants in a group of genes involved in transmission of signals by the neurotransmitter glutamate appear to increase the risk of depression. The report published in the journal Translational Psychiatry suggests that drugs targeting the glutamate system may help improve the limited success of treatment with current antidepressant drugs.

"Instead of looking at DNA variations one at a time, we looked at grouping of genes in the same biological pathways and found that a set of genes involved in glutamatergic transmisson was associated with the risk of depression," says Jordan Smoller, MD, ScD, director of the Psychiatric and Neurodevelopmental Genetics Unit in the Massachusetts General Hospital (MGH) Department of Psychiatry, senior author of the study. "Our findings are particularly interesting in light of recent studies showing that drugs affecting glutamate transmission can have rapid antidepressant effects."

While the risk of depression clearly runs in families, the genome-wide association studies typically used to identify gene variants that increase disease risk have been unable to find strongly associated genes. The research team which includes investigators from the Broad Institute of MIT and Harvard and other research centers in the U.S., Australia and the Netherlands adopted a strategy called gene set pathway analysis.

Starting with a set of genes that previous studies had implicated in depression, they used an analysis process called text mining to scan the medical literature for information on the biological function of these genes. Based on those findings, they identified 178 biological pathways that included these genes. Only one of those pathways the one involved in transmission of neural signals carried by glutamate was significantly associated with the risk for depression.

"Glutamate is the excitatory transmitter most widely used by the central nervous system, and several studies in animals and humans have suggested that it may play a role in depression," explains Smoller, an associate professor of Psychiatry at Harvard Medical School. "Most intriguingly, recent studies have found that ketamine a drug known to block one glutamate receptor appears to have antidepressant effects that are much faster than those of traditional antidepressants, which can take several weeks to become effective. Now additional research needs to confirm these findings and investigate exactly how variation in glutamate function affects brain systems involved in depression."


'/>"/>

Contact: Kory Zhao
kzhao2@partners.org
617-726-0274
Massachusetts General Hospital
Source:Eurekalert

Related medicine news :

1. ADHD medicine affects the brains reward system
2. Using Canadas Health System as Model Might Cut U.S. Costs: Study
3. Students win $100K for 3-D printer to turn waste plastic into composting toilets, rainwater systems
4. Systems biologist receives $2.5 million Pioneer Award for genome research
5. FDA OKs First Ultrasound Imaging System for Dense Breasts
6. U.S. Health Care System Wastes $750B Annually, Report Finds
7. Transformation of health system needed to improve care and reduce costs
8. Alternatives to Medicares fee-for-service payment system examined
9. PharmaNet system dramatically reduced inappropriate prescriptions of potentially addictive drugs
10. Study looks at efforts to improve local food systems through policy
11. Immune system protein could explain pancreatitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Cary, NC (PRWEB) , ... May 04, 2016 , ... ... database in the world. The Duke Clinical Research Institute (DCRI) and analytics leader SAS ... of cardiovascular patient data collected by the Duke University Health System. , The ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance of Northeast ... the people of their local community. The agency pledges to select a new ... hope is to bring awareness to important local causes with fundraising and other ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... May kicked ... in people across the United States. Dermatologist Dr. Ellen Turner is encouraging her patients, ... experts’ advice and focus on skin safety and health now and in the future. ...
(Date:5/4/2016)... ... 04, 2016 , ... Dr. Elyson and Dr. Assili, dentist in Northridge ... Wisdom tooth removal, a common dental procedure, is performed for many adolescents and young ... resulting in risks of complications. By providing wisdom tooth removal surgery at their office, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals announces another ... metabolic health. This synergistic combination of omega-3 fatty acids and potent antioxidants contains ... of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , Each nutrient ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... LAKE OSWEGO, Ore. , May 3, 2016 ... and endovascular medical technology, today announced Food and ... a cardiac resynchronization defibrillator that provides heart failure ... (MRI) scans. Iperia devices also have remote monitoring ... (CLS) that adapts the heart rate in response ...
(Date:5/3/2016)... YORK , May 3, 2016 ... (MRI) Market Size, Share, Development, Growth and Demand Forecast ... Open), by Field Strength (High Field, Very High Field, ... Application (Brain, Head and Neck, Spine, Musculoskeletal, Vascular, Breast, ... the global magnetic resonance imaging (MRI) market was valued ...
(Date:5/3/2016)... 2016 Norgine B.V. ... einen entscheidenden Meilenstein durch diese Veröffentlichung zur  ... Handeln, um Patientenresultate  bei Verdauungs- und Lebererkrankungen ... im Verständnis der Hepatischen Enzephalopathie bei und ... Hepatische Enzephalopathie in der Öffentlichkeit zu schaffen ...
Breaking Medicine Technology: